Evidence map›Paper›PMID 40212807›Full record

ArticleFASEB bioAdvances2025

Characterization of the

Shiho Nishino, Misuzu Hashimoto, Swapna Paramanya Biswas, Natsuki Mikami, Yoshikazu Hasegawa, Hayate Suzuki, Woojin Kang, Seiya Mizuno, Kazuya Murata

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FASEB bioAdvances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Characterization of theFASEB bioAdvances · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiho NishinoLaboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Misuzu HashimotoLaboratory of Biological Chemistry, Faculty of Applied Biological Sciences Gifu University Gifu Japan.ORCID https://orcid.org/0000-0002-7882-9885
Swapna Paramanya BiswasLaboratory of Biological Chemistry, Faculty of Applied Biological Sciences Gifu University Gifu Japan.
Natsuki MikamiProgram in Human Biology, School of Integrative and Global Majors University of Tsukuba Tsukuba Japan.
Yoshikazu HasegawaLaboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine University of Tsukuba Tsukuba Ibaraki Japan.
Hayate SuzukiLaboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine University of Tsukuba Tsukuba Ibaraki Japan.ORCID https://orcid.org/0009-0008-0447-6264
Woojin KangLaboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine University of Tsukuba Tsukuba Ibaraki Japan.ORCID https://orcid.org/0000-0002-4880-3406
Seiya MizunoLaboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine University of Tsukuba Tsukuba Ibaraki Japan.ORCID https://orcid.org/0000-0002-6740-5817
Kazuya MurataLaboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine University of Tsukuba Tsukuba Ibaraki Japan.ORCID https://orcid.org/0000-0002-3328-069X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo cell type-specific genetic recombination based on the Cre-loxP system has contributed to the understanding of biological processes and diseases. Neuronal nuclei (NeuN)/RBFOX3 is a widely used mature neuron marker in developmental biology and neuroscience. Here, we generated

Indexed as

bladderCre‐loxPgene recombinationgermlineheartknock‐in micenervous systemNeuNneuronRBFOX3

Identifiers

PMID40212807
PMCPMC11980809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.